NOCD raises $34M to end the global OCD crisis
HPA is excited to announce that NOCD, the world’s leading provider of obsessive compulsive-disorder (OCD) treatment, raised $34M in new funding. The round was co-led by Cigna Ventures and 7wireVentures, with participation from new investor Longitude Capital and other existing investors. HPA first invested in NOCD’s $4M round in 2019 and in the $12M Series […]